222 related articles for article (PubMed ID: 1478348)
21. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.
Sheridan PL; Bodner M; Lynn A; Phuong TK; DePolo NJ; de la Vega DJ; O'Dea J; Nguyen K; McCormack JE; Driver DA; Townsend K; Ibañez CE; Sajjadi NC; Greengard JS; Moore MD; Respess J; Chang SM; Dubensky TW; Jolly DJ; Sauter SL
Mol Ther; 2000 Sep; 2(3):262-75. PubMed ID: 10985957
[TBL] [Abstract][Full Text] [Related]
22. Retroviral vectors for liver-directed gene therapy.
Kalpana GV
Semin Liver Dis; 1999; 19(1):27-37. PubMed ID: 10349681
[TBL] [Abstract][Full Text] [Related]
23. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
Chan LM; Coutelle C; Themis M
Gene Ther; 2001 May; 8(9):697-703. PubMed ID: 11406764
[TBL] [Abstract][Full Text] [Related]
24. Use of helper cells with two host ranges to generate high-titer retroviral vectors.
Cosset FL; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina RM; Faure C; Nigon VM; Verdier G
Virology; 1993 Mar; 193(1):385-95. PubMed ID: 8382402
[TBL] [Abstract][Full Text] [Related]
25. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
26. From leading role to the backstage: mesenchymal stem cells as packaging cell lines for in situ production of viral vectors.
Silva FH; Nardi NB
Med Hypotheses; 2006; 67(4):922-5. PubMed ID: 16737782
[TBL] [Abstract][Full Text] [Related]
27. [Bio-safety testing for retroviral vector as gene therapy delivery system].
Zhu M; Dai Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):48-50. PubMed ID: 12759953
[TBL] [Abstract][Full Text] [Related]
28. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.
Patience C; Takeuch Y; Cosset FL; Weiss RA
Dev Biol (Basel); 2001; 106():169-79; discussion 253-63. PubMed ID: 11761229
[TBL] [Abstract][Full Text] [Related]
29. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
Kondo T; Ikeda K; Matsuo K
Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037
[TBL] [Abstract][Full Text] [Related]
30. Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific MAbs.
De Monte L; Nisticó P; Tecce R; Dellabona P; Momo M; Tarditi L; Natali PG; Mariani M; Malavasi F
Dev Biol Stand; 1990; 71():15-22. PubMed ID: 2401381
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene.
Kobinger GP; Mouland AJ; Lalonde JP; Forget J; Cohen EA
Gene Ther; 1997 Aug; 4(8):868-74. PubMed ID: 9338017
[TBL] [Abstract][Full Text] [Related]
32. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
33. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
[TBL] [Abstract][Full Text] [Related]
34. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O
Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
[TBL] [Abstract][Full Text] [Related]
35. Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer.
Ban J; First NL; Temin HM
J Gen Virol; 1989 Aug; 70 ( Pt 8)():1987-93. PubMed ID: 2549178
[TBL] [Abstract][Full Text] [Related]
36. Production of retroviral vectors.
Miller AD
Curr Protoc Hum Genet; 2001 May; Chapter 12():Unit 12.5. PubMed ID: 18428250
[TBL] [Abstract][Full Text] [Related]
37. Production of replication-defective retrovirus by transient transfection of 293T cells.
Gavrilescu LC; Van Etten RA
J Vis Exp; 2007; (10):550. PubMed ID: 18989403
[TBL] [Abstract][Full Text] [Related]
38. Retrovirus packaging cells.
Miller AD
Hum Gene Ther; 1990; 1(1):5-14. PubMed ID: 2081186
[TBL] [Abstract][Full Text] [Related]
39. PCR and other test systems in human gene therapy.
Morgan RA; Anderson WF
Dev Biol Stand; 1992; 76():171-7. PubMed ID: 1478336
[TBL] [Abstract][Full Text] [Related]
40. Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells.
Wahlfors JJ; Xanthopoulos KG; Morgan RA
Hum Gene Ther; 1997 Nov; 8(17):2031-41. PubMed ID: 9414252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
